At the time of PDUFA’s initial passage in 1992, some analysts raised worries that introducing equally person fees along with a recurring need to reauthorize their selection would undermine the agency’s independence within the regulated market.ten As a consequence of FDA’s budgetary dependence on sector consumer expenses, field has the advanta